Selecta Biosciences (SELB) Tops Q1 EPS by 34c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ENPH
2. HOOD
3. BA
4. STX
5. NXPI
6. SPY
7. NOW
8. GOOGL
9. KIDS
10. GOOG

Go back to Selecta Biosciences (SELB) Tops Q1 EPS by 34c

Selecta Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update

May 5, 2022 7:30 AM EDT

Phase 1 trial of SEL-302 remains on track to initiate in the second half of 2022

DISSOLVE I & II studies on track for completion in Q4 2022 with joint topline readout in Q1 2023

Completed underwritten offering, raising approximately $38.7 million in gross proceeds, extending runway into mid-2024

As of April 11, 2022, Selecta had approximately $154.2 million in cash, cash equivalents, restricted cash and marketable securities

Selecta to host conference call today at 8:30 AM ET

WATERTOWN, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a... More